Hellen Houlleberghs
Hellen has an international academic background with a BSc in Medical Biochemistry from King’s College, University of London, an MSc in Biomedical Sciences and Management from the University of Leiden, and a PhD in oncology from the Netherlands Cancer Institute.
Hellen has worked on primary as well as applied research, with a PhD that focused on the development and diagnostic use of a genetic screen for the identification of subjects at risk of developing hereditary colorectal cancer.
Hellen has nearly a decade of experience in clinical operations, working on both the industry’s Sponsor and Clinical Research Organization sides.
Hellen has managed global phase I to III trials in various indications, including rare diseases, for small and large pharmaceutical companies.
Hellen is a proactive, creative problem solver and enthusiastic, collaborative, methodological clinical operations professional who is driven to achieve the best possible result.
